Literature DB >> 16408201

Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease.

R J Cordery1, D MacManus, A Godbolt, M N Rossor, A D Waldman.   

Abstract

Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative disorder. Clinical diagnosis is difficult in the early stages as the disease often presents with non-specific psychiatric and neurological symptoms. To investigate the diagnostic potential of quantitative short TE in vivo MRS, and the nature and anatomical distribution of biochemical abnormalities in vCJD, localised single-voxel spectra (TE/TR 30 ms/2,000 ms) were acquired from three brain regions: thalami, caudate nuclei and frontal white matter. Metabolite concentrations and ratios from three patients with definite or probable vCJD were compared with eight normal age-matched controls. Abnormal signal on T2-weighted MRI was apparent in the pulvinar region in all vCJD patients; this region also showed greatly increased myo-inositol [MI] (mean 2.5-fold, P=0.01) and decreased N-acetyl-aspartate (NAA; mean 2-fold, P=0.01). Two patients also showed increased [MI] (z=17, 11; one with decreased NAA, z=-12) in normal-appearing caudate nuclei. The magnitude of metabolite abnormalities in the thalami in moderately advanced vCJD suggests a potential role in earlier diagnosis. Short TE protocols allow the measurement of MI, which adds discriminant power to the MRS examination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16408201     DOI: 10.1007/s00330-005-0090-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Florid plaques and new variant Creutzfeldt-Jakob disease.

Authors:  J W Ironside; J E Bell
Journal:  Lancet       Date:  1997-11-15       Impact factor: 79.321

2.  Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease.

Authors:  P Demaerel; A L Baert; L Vanopdenbosch; W Robberecht; R Dom
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

3.  Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI.

Authors:  M Matoba; H Tonami; H Miyaji; H Yokota; I Yamamoto
Journal:  J Comput Assist Tomogr       Date:  2001 Mar-Apr       Impact factor: 1.826

4.  Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease.

Authors:  H G Pandya; S C Coley; I D Wilkinson; P D Griffiths
Journal:  Clin Radiol       Date:  2003-02       Impact factor: 2.350

5.  Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease.

Authors:  M M Bahn; P Parchi
Journal:  Arch Neurol       Date:  1999-05

6.  Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease.

Authors:  K Konaka; M Kaido; Y Okuda; F Aoike; K Abe; T Kitamoto; T Yanagihara
Journal:  Neuroradiology       Date:  2000-09       Impact factor: 2.804

7.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.

Authors:  A Brand; C Richter-Landsberg; D Leibfritz
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

8.  Rapid echoplanar diffusion imaging in a case of variant Creutzfeldt-Jakob disease; where speed is of the essence.

Authors:  Adam D Waldman; Paul Jarman; Robert T G Merry
Journal:  Neuroradiology       Date:  2003-07-17       Impact factor: 2.804

9.  Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease.

Authors:  G D Graham; O A Petroff; A M Blamire; G Rajkowska; P Goldman-Rakic; J W Prichard
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

10.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

View more
  10 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

Review 2.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

3.  MRS in early and presymptomatic carriers of a novel octapeptide repeat insertion in the prion protein gene.

Authors:  Eric M McDade; Bradley F Boeve; Julie A Fields; Neeraj Kumar; Rosa Rademakers; Matt C Baker; Bsc David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2012-05-21       Impact factor: 2.486

4.  Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases.

Authors:  Damien Galanaud; S Haik; M G Linguraru; J-P Ranjeva; B Faucheux; E Kaphan; N Ayache; J Chiras; P Cozzone; D Dormont; J-P Brandel
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

5.  Neuroimaging in human prion disease: Searching in the mist.

Authors:  Panayotis Ioannides; Dimitris Karacostas
Journal:  World J Radiol       Date:  2009-12-31

6.  In Vivo Longitudinal (1)H MRS Study of Transgenic Mouse Models of Prion Disease in the Hippocampus and Cerebellum at 14.1 T.

Authors:  Cristina Cudalbu; Melanie Craveiro; Vladimir Mlynárik; Juliane Bremer; Adriano Aguzzi; Rolf Gruetter
Journal:  Neurochem Res       Date:  2015-07-23       Impact factor: 3.996

7.  Genomic and post-genomic analyses of human prion diseases.

Authors:  Maurizio Pocchiari; Anna Poleggi; Serena Principe; Silvia Graziano; Franco Cardone
Journal:  Genome Med       Date:  2009-06-22       Impact factor: 11.117

8.  Quantitative proton magnetic resonance spectroscopy detects abnormalities in dorsolateral prefrontal cortex and motor cortex of patients with frontotemporal lobar degeneration.

Authors:  Sanjeev Chawla; Sumei Wang; Peachie Moore; John H Woo; Lauren Elman; Leo F McCluskey; Elias R Melhem; Murray Grossman; Harish Poptani
Journal:  J Neurol       Date:  2009-08-18       Impact factor: 4.849

Review 9.  Neuroimaging findings in human prion disease.

Authors:  R G Macfarlane; S J Wroe; J Collinge; T A Yousry; H R Jäger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

10.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.